Get the Weekly Intelligence Brief — top committee picks every Sunday.
MFC · NYSE · STOCK

Manulife Financial (MFC) Stock Analysis

Financial Services Updated October 10, 2026
$42.44
52W $29.70 – $45.33
64/100
$70.81B
16.3
0.74
AI Committee Verdict
Buy
64/100
Conviction: High · 83% agreement · 6 analysts
+6.7%
-13.2%
0.51:1
High
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is MFC Bullish or Bearish?

Bullish. Innellis AI committee rates Manulife Financial Corporation (MFC) Buy with a composite score of 64/100 , based on 6 analysts with 83% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +10.71 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -9.29 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.29) -- balance sheet can absorb a shock. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • P/E of 14.8 is inexpensive for the broad market — Value
  • Dividend yield of 5.5% pays you to wait — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Low leverage (debt-to-equity 0.29) -- balance sheet can absorb a shock — Risk
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
64/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 25%
of 211 Financial Services peers
Value Analyst bullish
68 / 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 14.8 is inexpensive for the broad market
Growth Analyst bullish
62 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bullish
80 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.29) -- balance sheet can absorb a shock
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 64.3 to 64.3.

Analyst-level changes:
  • Value Analyst: +1 bullish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
41.6
Neutral
MACD Histogram
-0.159
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$36.84
Resistance
$45.28
Bollinger %B
0.21
Inside Bands
Price vs Moving Averages
EMA 9
$42.65 Below
EMA 21
$43.04 Below
EMA 50
$43.01 Below
EMA 200
$39.80 Above

Fundamental Analysis

Valuation
96
Growth
63
Profitability
40
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio 16.3×
P/B Ratio 1.90×
PEG Ratio 0.88
Dividend Yield 3.13%
52W High $45.33
52W Low $29.70
Quality & Growth
ROE 1134.7%
ROA 56.4%
Gross Margin 3659.4%
Operating Margin 1446.0%
Revenue Growth YoY —
Debt / Equity 0.27
AI Fundamental Assessment
P/E ratio of 16.3 (inexpensive relative to a 15-40x range); Price-to-book of 1.9x; PEG ratio of 0.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.3%; Return on assets of 0.6%; Net margin of 11.6%; Gross margin of 36.6%; Current ratio of 2.36 (healthy short-term liquidity); Debt-to-equity of 0.27; Free cash flow per share is positive (18.45); Most recent quarter beat estimates by 0.3%; EPS growth accelerating (-5.4% -> +2.8% QoQ); Analyst estimates flat over recent quarters
Get the Full MFC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime